Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis.
Camille RoubilleAmandine CoffyNathalie RinchevalMaxime DougadosRené-Marc FlipoJean-Pierre DaurèsBernard G CombePublished in: Rheumatology (Oxford, England) (2021)
(ClinicalTrials.gov Identifier: NCT03666091).